STAA

STAAR Surgical Company (NASDAQ:STAA) is a California-based medical device company founded in 1982 and publicly traded since 1992. The company specializes in designing, developing, manufacturing and marketing implantable lenses for vision correction procedures. STAAR has established itself as a leading player in the refractive surgery market, with particular strength in the implantable collamer lens (ICL) segment. The company operates globally with direct sales operations in major markets including the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, while serving other international markets through distributors and representatives.